Society of Toxicology Annual Meeting (SOT 2019)
The 58th Annual Meeting and ToxExpo will be held in Baltimore at the Convention Center on March 10–14, 2019. Featuring more than 100 Featured and Scientific Sessions and 2,100 individual presentations, the SOT Annual Meeting covers basic and cuttingedge science in dozens of toxicological subdisciplines and provides a wealth of information for all career levels, from students to advanced-career toxicologists.
Returning for the 2019 meeting are the all-day Poster Sessions introduced last year, and per attendees’ suggestion, SOT will pilot 90-minute Symposium and Workshop Sessions on Tuesday afternoon as part of this year’s scientific program. Beyond the scientific program sessions, attendees will enjoy hundreds of additional events, including activities hosted by SOT Regional Chapters, Special Interest Groups, and Specialty Sections; Exhibitor-Hosted Sessions; and other ancillary meetings.
Schedule
12 March
U Doshi
Comparison of the impacts of an acute exposure to electronic cigarette aerosol and cigarette smoke on small airway epithelial cultures: In vitro systems toxicology assessment
12 March
R Li
Systems toxicology approach for the assessment of zebrafish neurotoxicity
12 March
V Belcastro
GladiaTOX: global assessment of dose-response indicators in toxicology
12 March
D Marescotti
Systems toxicology assessment of a representative e-liquid formulation using human primary bronchial epithelial cells
12 March
A Iskandar
Exposure to an aerosol from a novel electronic cigarette using the MESH™ technology elicited reduced biological impacts than exposure to cigarette smoke on buccal and small airway epithelial cultures: A systems toxicology assessment
12 March
S Frentzel
Human multi-organ-chip co-culture approach of bronchial airway
12 March
NV Ivanov
Xenobiotic metabolism response to 3R4F or THS 2.2 exposure: from pre-clinical to clinical
12 March
A Kuczaj
A method for determination of tracheobronchial airway geometries from four different species/strains of mice
12 March
D Marescotti
Systems toxicology assessment of a representative e-liquid formulation using human primary bronchial epithelial cells
14 March
J Szostak
A six-month inhalation study in ApoE-/- mice to investigate cardiovascular and respiratory exposure effects of e-vapor aerosols compared with cigarette smoke
